An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma

Clinical trial NCT01609036 · TERMINATED

Trial details

NCT number: NCT01609036
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Study type: OBSERVATIONAL

Lymphoma, Follicular

Start date: 2012-10-01
Primary completion: 2012-11-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.